Cited by 32Effects and risks of endocrine disrupting chemicalsHealth, Environment, Cognitive AgingBirth, Development, and Health

Pregnancy-related maternal physiological adaptations and fetal chemical exposure

Open access
Vinnars, Marie-Therese, Bixo, Marie, Damdimopoulou, Pauliina·2023·Molecular and Cellular Endocrinology

Abstract

Prenatal life represents a susceptible window of development during which chemical exposures can permanently alter fetal development, leading to an increased likelihood of disease later in life. Therefore, it is essential to assess exposure in the fetus. However, direct assessment in human fetuses is challenging, so most research measures maternal exposure. Pregnancy induces a range of significant physiological changes in women that may affect chemical metabolism and responses. Moreover, placental function, fetal sex, and pregnancy complications may further modify these exposures. The purpose of this narrative review is to give an overview of major pregnancy-related physiological changes, including placental function and impacts of pregnancy complications, to summarize existing studies assessing chemical exposure in human fetal organs, and to discuss possible interactions between physiological changes and exposures. Our review reveals major knowledge gaps in factors affecting fetal chemical exposure, highlighting the need to develop more sophisticated tools for chemical health risk assessment in fetuses.

AI snapshot

Written from the paper’s full text.

TL;DR

This narrative review argues that pregnancy-related maternal physiological adaptations, placental function, fetal sex, and pregnancy complications can modify fetal chemical exposure, but direct human fetal exposure data remain sparse. It synthesizes maternal/placental physiology and human fetal tissue studies to highlight major knowledge gaps for fetal chemical risk assessment.

Key findings

  • Pregnancy induces major cardiovascular, renal, metabolic, endocrine, and immune changes—e.g., cardiac output increases by 30–50% and GFR increases by more than 50%—which may alter chemical absorption, distribution, metabolism, and excretion, thereby influencing fetal exposure.
  • Placental function and fetal sex modify exposure: placental insufficiency, gestational diabetes, and hypertensive disorders alter placental structure/transport; one study found the highest exposures in full-term pregnancies with male fetuses and normally functioning placentas, and lipophilic pollutants accumulated in fetal adipose tissue up to 100-fold higher than in placental tissue.
  • Human fetal tissue studies show chemicals cross the placenta and deposit in vital organs; detected chemicals include organochlorine pesticides, PCBs, PBDEs, PFAS, organophosphate pesticides, and bisphenol A, with reported concentrations ranging from not detected to μg-ng/g (ppm-ppb) and high inter-individual variation. The largest study included 85 fetuses, and the median sample size was 44.
  • Knowledge gaps remain: only 500 of 100,000 chemicals on the EU market have been thoroughly risk assessed, the world market is estimated at approximately 350,000 chemicals, and common pregnancy complications—gestational diabetes at 14% and hypertensive disorders at 10%—are often excluded from studies.

Methods

  • Narrative review; no primary data. It synthesizes literature on maternal physiological adaptations in normal and complicated pregnancy, placental development and function, human fetal chemical exposure studies, and in silico pregnancy physiologically based pharmacokinetic/toxicokinetic (p-PBPK/PBTK) models.
  • For fetal exposure, it reviews studies in Table 1 measuring industrial chemical residues in human fetal and neonatal tissues from elective pregnancy terminations, stillbirths, and perinatal autopsies, mostly from North America and Europe.
  • Main analysis is qualitative synthesis; no systematic search strategy or meta-analysis is described.

Limitations

  • The paper states major knowledge gaps: factors affecting fetal chemical exposure are poorly understood; fetal tissue studies have small sample sizes, cover limited chemicals and geographic regions, and p-PBPK models face validation challenges; causality is difficult to establish from epidemiological associations.
  • The paper notes that fetal tissue studies rely on non-viable pregnancies (terminations, stillbirths, neonatal deaths), often with anonymized samples and limited maternal/fetal data, and that analytical methods have changed markedly over half a century, limiting comparability.
  • Evident from the text: as a narrative review, it does not report a systematic search or formal quality assessment, and the reviewed studies are heterogeneous in design, tissues, chemicals, and reporting.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.mce.2023.112064

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

39 of 79 cited sources checked · 17 supported · 1 flagged · accuracy not yet measured

  • Premisecitation
    § 1.1. Exposure to human-made chemicals is common · p. 1

    Mixtures of industrial chemical residues are commonly present in the blood and urine of diverse populations.

    “Multiple biomonitoring studies have found that mixtures of industrial chemical residues are commonly present in the blood and urine of diverse populations (Crinnion, 2010; Porta et al., 2008; Dominguez-Romero et al., 2023; Tkalec et al., 2022; Woodruff et al., 2011).”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites Crinnion, 2010
    • cites Porta et al., 2008 source
    • cites Dominguez-Romero et al., 2023 source

      The Introduction (page unavailable) reports that phthalates were detected in more than 90% of urine samples from general populations in Asian, European, and North American countries. The paper also analyzes urinary metabolites of several phthalates and substitutes, but it does not establish that mixtures of industrial chemical residues are commonly present in blood. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation
    § 1.3. Assessing chemical risks in the fetus is challenging · p. 2

    Concentrations of persistent EDCs between fetal organs differed by several orders of magnitude.

    “Furthermore, concentrations between fetal organs also differed by several orders of magnitude (Bjorvang et al., 2021).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Bjorvang et al., 2021 source

      Section 3.3 reports distinct concentration patterns across fetal organs, with the highest tissue-to-serum ratios in adipose tissue and the lowest among fetal organs in the brain. But the reported ranges do not establish that concentrations between fetal organs generally differed by several orders of magnitude. Section 3.6 gives total burdens of 40,000 pg/g in adipose tissue and 1,100 pg/g in brain—about a 36-fold difference. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation
    § 3.6. Altered placental function · p. 7

    Inadequate placentation is seen in several common obstetrical syndromes, including fetal growth restriction, spontaneous second trimester miscarriages, placental abruption, preterm birth, and hypertensive disorders in pregnancy.

    “Inadequate placentation is seen in several common obstetrical syn­ dromes, including fetal growth restriction, spontaneous second trimester miscarriages, placental abruption, preterm birth, and hyper­ tensive disorders in pregnancy (Brosens et al., 2011).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Brosens et al., 2011 source
  • Premisecitation
    § 3.6. Altered placental function · p. 7

    As non-transformed arteries still constrict in response to vaso-constricting signals, there is a risk of ischemia-reperfusion damage to the villi.

    “As the non-transformed arteries still constrict in response to vaso-constricting signals, there is also a risk of ischemia-reperfusion damage to the villi (Staff et al., 2022).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Staff et al., 2022 source
  • Interpretationreasoning
    § 3.4. Placental function by fetal sex · p. 6

    The higher vulnerability in males and improved outcomes in females when the intrauterine milieu changes and becomes less hospitable is most likely explained by sex differences in fetal growth strategy and reserve capacity.

    “This most likely explains the higher vulnera­ bility in males and the improved outcomes in females seen when the intrauterine milieu changes and become less hospitable (Meakin et al., 2021; Teulings et al., 2020).”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Meakin et al., 2021 source
    • cites Teulings et al., 2020 source

      The Conclusions (page unavailable) report a higher incidence of placenta-mediated pathologies in pregnancies with male rather than female fetuses, supporting the male-vulnerability part. The Discussion and Conclusions do not establish improved female outcomes when the intrauterine environment becomes less hospitable or explain the difference through fetal growth strategy and reserve capacity; the Discussion says the mechanism underlying the observed sex difference is unknown. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. 29
  • May combine two claims. 38
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    The Loccisano model considered the fetus as one compartment.

    “The model considered the fetus as one compartment, and concluded that more studies are needed to better model the various factors affecting chem­ icals during pregnancy, such as possible changes in renal reabsorption of PFAS.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Loccisano et al., 2013 source

      The Methods section (Gestation model–physiology; page not provided) explicitly describes three fetal compartments, contrary to the claim that the fetus was modeled as one compartment. The Discussion does call for more data on renal resorption, but that does not support the compartment claim. (LLM, conf=0.94)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation
    § 3.4. Placental function by fetal sex · p. 6

    Fetuses of different sexes respond differently to changes in the intrauterine milieu: male fetuses prioritize growth, whereas female fetuses show increased adaptability and higher reserve capacity.

    “In addition, fetuses of different sexes respond differently; while male fetuses prioritize growth, the females show increased adaptability and higher reserve capacity.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Meakin et al., 2021 source
    • cites Teulings et al., 2020 source

      The Introduction and Discussion (Main findings; page numbers unavailable) describe sex differences in placental development and vascular resistance, supporting the general point that fetal sex matters. They do not say that males prioritize growth or that females have greater adaptability or reserve capacity; the reference title about growth and survival does not establish those specific claims. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation
    § 3.6. Altered placental function · p. 7

    Gestational diabetes is associated with disorders of placental insufficiency, such as hypertension in pregnancy and stillbirth, which could be explained by endothelial dysfunction of women with the metabolic syndrome.

    “Gestational diabetes is also associated with disorders of placental insufficiency, such as hypertension in pregnancy and stillbirth, which could be explained by the endothelial dysfunction of women with the metabolic syndrome (Rosenstein et al., 2012; Yang et al., 2022).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Rosenstein et al., 2012 source

      The Comment section (page not provided) reports that women with gestational diabetes were more likely to experience stillbirth after 35 weeks. The paper does not establish an association with hypertension in pregnancy or identify placental insufficiency or endothelial dysfunction in metabolic syndrome as an explanation. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites Yang et al., 2022 source

      The Mechanism and Predictive Markers section (Figure 1; page not provided) links gestational diabetes to placental ischemia, vascular endothelial injury, and preeclampsia with hypertension. The Introduction also describes an association between gestational diabetes and preeclampsia. The passages do not establish the claimed association with stillbirth or specifically explain these outcomes through endothelial dysfunction in women with metabolic syndrome. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation
    § 3.6. Altered placental function · p. 7

    Gestational diabetes is associated with high aerobic fetal metabolism and hypoxia, stimulating the placenta to increase angiogenesis, resulting in increased number of capillaries; placentas also show abnormal endocrine function, increased inflammation, and changes in placental transporters.

    “Gestational diabetes is associated with high aerobic fetal metabolism and hypoxia, stimulating the placenta to in­ crease angiogenesis, resulting in increased number of capillaries. The placentas also show abnormal endocrine function, increased inflam­ mation, and changes in placental transporters (Bedell et al., 2021; Denison et al., 2010; Gaither et al., 1999; Segura et al., 2017”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites Bedell et al., 2021 source
    • cites Denison et al., 2010 source

      Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites Gaither et al., 1999 source
  • May combine two claims.

    Interpretationcitation
    § 3.4. Placental function by fetal sex · p. 5

    Placental differences dependent on fetal sex are numerous, and there are many mechanisms that could be involved in explaining how fetuses of different sexes are affected differently by prenatal EDC exposure.

    “However, the placental differences dependent on fetal sex are numerous, and there are many mechanisms that could be involved in explaining how fetuses of different sexes are affected differently by prenatal EDC exposure (Braun et al., 2022).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Braun et al., 2022 source

      The Background sections “The dynamic placental transcriptome” and “How does sex manifest in the human placenta?” describe numerous fetal-sex-dependent placental differences and potential mechanisms involving gene expression and hormones (page numbers unavailable). The passages do not connect those mechanisms specifically to differing fetal effects of prenatal endocrine-disrupting chemical (EDC) exposure. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation
    § 3.4. Placental function by fetal sex · p. 5

    Throughout gestation placental function is influenced by fetal sex, resulting in sex-specific immunological and hormonal signaling, as well as sex-specific metabolism.

    “Throughout gestation placental function is influenced by fetal sex, resulting in sex-specific immunological and hormonal signaling, as well as sex-specific metabolism (Braun et al., 2022).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Braun et al., 2022 source
  • May combine two claims.

    Premisecitation
    § 1.2. Fetal development is uniquely susceptible to chemical exposures · p. 2

    Exposure in utero to thalidomide caused severe malformations, and even fetal demise - effects that were not detected in the adult women taking the drug.

    “Exposure in utero to thalidomide caused severe malformations, and even fetal demise - effects that were obviously not detected in the adult women taking the drug (Vargesson, 2015).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Vargesson, 2015 source
  • May combine two claims.

    Premisecitation
    § 3.6. Altered placental function · p. 6

    Limited trophoblast invasion leads to inadequate placentation and a shallow placenta, with less frequent transformation of peripheral and deeper myometrial parts of the spiral arteries and development of atherosis.

    “A limited trophoblast invasion leads to inadequate placentation and a shallow placenta, with features illustrated in Fig. 3. The peripheral parts as well as the deeper myometrial parts of the spiral arteries are less often transformed and develop atherosis, a feature with many similar­ ities to atherosclerotic lesions (Pitz et al., 2021).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Pitz et al., 2021 source

      The Acute Atherosis Etiology section (page unavailable) links poor spiral-artery remodeling to acute atherosis and says the lesions share morphological features with early atherosclerosis. It also says atherosis is mainly found downstream at the tips of decidual spiral arteries, whereas the major remodeling problems occur upstream in the myometrium; atherosis can occur without remodeling defects. The source therefore does not support the claim that the less-transformed peripheral and deeper myometrial parts themselves generally develop atherosis. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Interpretationcitation
    § 3.6. Altered placental function · p. 6

    Consequently, blood flows at a higher rate towards the villi, probably damaging the terminal branches, causing inflammation and stress later seen in the placenta, and likely playing a role in the development of maternal symptoms seen in hypertensive disorders in pregnancy.

    “Consequently, the blood flows at a higher rate towards the villi, probably damaging the terminal branches, causing the inflammation and stress later seen in the placenta, likely playing a role in the development of the maternal symptoms seen in hypertensive disorders in pregnancy (Burton et al.,”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Burton et al., 2019 source
  • May combine two claims.

    Premisecitation
    § 3.5. Placental imprinting · p. 6

    Bisphenol A exposure is linked to altered methylation profiles in the human placenta and lower birth weight.

    “Also, bisphenol A has been linked to altered methylation profiles in the human placenta, as well as lower birth weight (Nahar et al., 2015; Troisi et al., 2014).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Nahar et al., 2015 source
    • cites Troisi et al., 2014 source
  • May combine two claims.

    Findingcitation
    § Table 1 · p. 10

    Concentrations in fetal tissues, normalized to maternal serum or placenta levels, were lower in pregnancies with female fetus, pregnancies with placental insufficiency, and pregnancies that ended earlier.

    “The concentrations in fetal tissues, normalized to maternal serum or placenta levels, were lower in pregnancies with female fetus, pregnancies with placental insufficiency, and pregnancies that ended earlier (Bjorvang et al., 2021).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Bjorvang et al., 2021 source

      Section 3.5 reports lower fetal tissue:maternal serum ratios with placental insufficiency, higher ratios for several chemicals in male than female fetuses, and positive associations between gestational age and several ratios during weeks 36–41. The comparisons by these three factors used maternal serum ratios, not tissue:placenta ratios, and the findings did not apply to every measured chemical or tissue. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation
    § 4.2. Factors influencing fetal chemical exposure · p. 8

    Compared to adult liver, fetal liver is immature in its capacity to metabolize xenobiotics; it expresses a different set of xenobiotic-metabolizing enzymes, and the total amount of cytochrome P450 activity in fetal liver is significantly lower than in adult liver.

    “Compared to adult liver, fetal liver is immature in its capacity to metabolize xenobiotics; it expresses a different set of xenobiotic-metabolizing enzymes, and the total amount of cytochrome P450 activity in fetal liver is significantly lower than in adult liver (Hakkola et al., 1998; Robinson et al., 2020).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Hakkola et al., 1998 source
    • cites Robinson et al., 2020 source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    Although DDT and PCBs have been globally restricted through the Stockholm Convention, they are still commonly detected in biomonitoring samples including human fetuses.

    “Although DDT and PCBs have been globally restricted through the Stockholm Convention, they are still, half a cen­ tury later, commonly detected in biomonitoring samples including human fetuses (Bjorvang et al., 2021).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Bjorvang et al., 2021 source
  • May combine two claims.

    Premisecitation
    § 4.2. Factors influencing fetal chemical exposure · p. 8

    Zota et al. found a significant correlation between fetal liver burden of PBDE and expression of CYP1A1, but no correlation to any other studied CYPs.

    “Zota et al. found significant correlation between fetal liver burden of PBDE and expression of CYP1A1 , but no correlation to any other studied CYPs (Zota et al., 2018).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Zota et al., 2018 source

      The Results report a positive association between fetal-liver PBDE levels and CYP1A1 expression, but its 95% confidence interval in the full sample includes 1 (OR 2.36, 95% CI 0.98–5.68); it was significant in the analysis restricted to never-smokers. The Results also describe a suggestive, non-significant association with liver CYP2J2, so saying there was no correlation with any other studied CYP overstates the finding. Page numbers are unavailable in our copy. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingcitation
    § Table 1 · p. 10

    The largest study included 85 fetuses, while the median sample size of the reported studies was 44.

    “The largest study included 85 fetuses (Zota et al., 2018), while the median sample size of the reported studies was 44 (Table 1).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Zota et al., 2018 source

      The Study Population section reports two cohorts of 36 and 50 women, and the Cytochrome P450 mRNA expression section reports 84 fetal-liver samples examined. These passages establish a study of roughly the stated size but do not substantiate exactly 85 fetuses. The median of 44 is attributed to the citing paper’s Table 1, not to Zota et al. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    The Loccisano model concluded that more studies are needed to better model factors affecting chemicals during pregnancy, such as possible changes in renal reabsorption of PFAS.

    “The model considered the fetus as one compartment, and concluded that more studies are needed to better model the various factors affecting chem­ icals during pregnancy, such as possible changes in renal reabsorption of PFAS.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Loccisano et al., 2013 source

      The Discussion (Gestation and Lactation Models; page not provided) calls for more kinetic data during pregnancy, including data on renal resorption of PFAAs, to improve model predictions. But the Methods (Gestation model–physiology; page not provided) describes fetal plasma, rest-of-body, and amniotic-fluid compartments—not the fetus as a single compartment. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 5. Summary and future Directions · p. 11

    Hypertensive pregnancy disorders affect 10% of pregnancies.

    “hypertensive pregnancy disorders 10% (Cameron et al., 2022)”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Cameron et al., 2022 source

      The Methods and Results section (page unavailable) reports new-onset hypertensive disorders in 2019 at 83.9 per 1,000 rural live births and 77.2 per 1,000 urban live births—about 8%, not 10%. The study covers US live births, so it does not establish a 10% figure for pregnancies generally. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    Loccisano et al. developed a human p-PBTK model for PFOS and PFOA based on earlier adult human models.

    “For example, Loccisano et al. developed a human p-PBTK model for PFOS and PFOA based on earlier adult human models (Loccisano et al., 2013).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Loccisano et al., 2013 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    The method of pregnancy termination can vary from mechanical to pharmaceutical, and the possible impact of the method on chemicals in the collected samples has not been assessed.

    “The method of pregnancy termination can vary from mechanical to pharmaceutical, and the possible impact of the method on chemicals in the collected samples has not been assessed.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    Samples representing the first half of pregnancy are often collected from elective pregnancy terminations, and studies covering the latter half are typically based on tissues collected during autopsies of stillborn infants and neonatal deaths.

    “Samples representing the first half of pregnancy are often collected from elective pregnancy terminations, and the studies covering the latter half of the pregnancy are typically based on tissues collected during au­ topsies of stillborn infants and neonatal deaths (Table 1).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given
    § Table 1 · p. 10

    Half of the studies mentioned some maternal physiological factors, but their role in fetal exposure levels were considered only in a few studies.

    “Half of the studies mentioned some maternal physiological factors, but their role in fetal exposure levels were considered only in a few studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Table 1 · p. 10

    Another common feature of fetal chemical exposure studies is the reported large variation between studied individual fetuses.

    “Another common feature is the reported large variation between studied individual fetuses.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § 4.2. Factors influencing fetal chemical exposure · p. 8

    Older studies (1969-2007) were conducted with tissues collected from stillbirth and perinatal autopsies, covering the latter half of pregnancy and first weeks of life, whereas newer studies (2009-2018) focused on elective pregnancy terminations, primarily covering the first trimester.

    “The older studies (1969 -2007) were conducted with tissues collected from stillbirth and perinatal autopsies, and therefore covered the latter half of pregnancy and the first weeks of life, whereas the newer studies (2009 -2018) focused on elective preg­ nancy terminations, primarily covering the first trimester of pregnancy (Table 1).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingreasoning
    § 4.2. Factors influencing fetal chemical exposure · p. 8

    The most-often studied fetal organ is the liver.

    “The most-often studied fetal organ is the liver.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Table 1 · p. 10

    In many cases, samples were anonymized and associated information was limited to fetal age and sex.

    “In many cases, samples were ano­ nymized and associated information was limited to fetal age and sex (Table 1).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisenone given
    § 1.1. Exposure to human-made chemicals is common · p. 1

    Direct assessment of chemical exposure in human fetuses is challenging, so most research measures maternal exposure.

    “However, direct assessment in human fetuses is challenging, so most research measures maternal exposure.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given
    § 1.1. Exposure to human-made chemicals is common · p. 1

    Placental function, fetal sex, and pregnancy complications may further modify fetal chemical exposure.

    “Moreover, placental function, fetal sex, and pregnancy complications may further modify these exposures.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § 1.1. Exposure to human-made chemicals is common · p. 1

    Prenatal life is a susceptible window of development during which chemical exposures can permanently alter fetal development, leading to an increased likelihood of disease later in life.

    “Prenatal life represents a susceptible window of development during which chemical exposures can permanently alter fetal development, leading to an increased likelihood of disease later in life.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Ghassabian et al., 2022 source
  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning
    § 1.1. Exposure to human-made chemicals is common · p. 1

    The review reveals major knowledge gaps in factors affecting fetal chemical exposure, highlighting the need to develop more sophisticated tools for chemical health risk assessment in fetuses.

    “Our review reveals major knowledge gaps in factors affecting fetal chemical exposure, highlighting the need to develop more sophisticated tools for chemical health risk assessment in fetuses.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § 3.6. Altered placental function · p. 7

    Gestational diabetes is characterized by increased insulin resistance and insufficient beta-cell insulin production.

    “Another common pregnancy complication is gestational diabetes, characterized by increased insulin resistance and insufficient beta-cell insulin production (Szlapinski et al., 2021).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Szlapinski et al., 2021 source
  • May combine two claims.

    Premisecitation
    § 3.5. Placental imprinting · p. 6

    Maternal phthalate exposure is associated with imprinting of IGF2 in the placenta and low birth weight.

    “Associations have been found between maternal phthalate exposure, imprinting of IGF2 in the placenta, and low birth weight (Zhao et al., 2015, 2016).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Zhao et al., 2015, 2016

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationreasoning
    § 3.3. Placental bed barrier · p. 5

    As entire cells can pass the placental barrier, it is likely that EDCs pass the barrier too.

    “As entire cells can pass the barrier, it is likely that EDCs pass the barrier too.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § 3.1. Overview of placental formation · p. 5

    As the smooth muscle cells of the spiral arteries are replaced by trophoblasts, they become non-responsive to vasoconstricting substances, offering the fetus an unconditional supply of oxygen and nutrition, but also exposing it to other substances present in the maternal circulation.

    “As the smooth muscle cells of the vessel walls are replaced by trophoblasts, they become non-responsive to vasoconstricting substances. This offers the fetus an unconditional supply of oxygen and nutrition, but also exposes it to other substances present in the maternal circulation (Cunningham, 2022).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Cunningham, 2022

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning
    § 2.6. The immune system and inflammation · p. 5

    Physiological (mal)adaptation is likely to alter the fetal chemical burden, adding a further layer of complexity to studies assessing associations between maternal chemical exposure and fetal development and post-natal health.

    “In addition, physiological (mal)adaptation is likely to alter the fetal chemical burden, adding a further layer of complexity to studies assessing associations between maternal chemical exposure and fetal development and post-natal health.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisenone given
    § 3. Placental development and function · p. 5

    The placenta plays a major role as a barrier, as well as enabling waste disposal, gas exchange, and nutrient supply.

    “The placenta is one of the most essential maternal organs for the fetus, playing a major role as a barrier, as well as enabling waste disposal, gas exchange, and nutrient supply.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § 1.4. New approaches in chemical safety assessment · p. 2

    Pregnancy complications widen the variation in physiological adaptations even more.

    “In addition, pregnancy complications widen the variation even more.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § 1.3. Assessing chemical risks in the fetus is challenging · p. 2

    It is a challenge to demonstrate a causal mode of action in humans, and in practice data has to be collected by combining multiple lines of evidence.

    “It is a challenge to demonstrate a causal mode of action in humans, and in practice data has to be collected by combining multiple lines of evidence.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given
    § 3.6. Altered placental function · p. 8

    Many pregnant women suffer from common pregnancy complications associated with altered placental function.

    “In summary, many pregnant women suffer from common pregnancy complications associated with altered placental function.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationcitation
    § 2.1. Adaptation and maladaptation in pregnancy · p. 4

    Overall, pregnant women are more sensitive to chemical exposure than non-pregnant women due to the physiological changes, more prone to develop pregnancy-related complications due to the exposure, and almost certainly even more vulnerable when pregnancy complications are already present.

    “Overall, pregnant women are more sensitive to chemical exposure than non-pregnant women due to the physiological changes, more prone to develop pregnancy-related complications due to the exposure, and almost certainly even more vulnerable when pregnancy complications are already present (Gomez-Roig et al., 2021).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Gomez-Roig et al., 2021 source
  • May combine two claims.

    Premisecitation
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    In fetal and neonatal deaths, causes of death may relate to severe malformations or chromosomal abnormalities, but are also often findings compatible with live births, such as placental insufficiency, intrauterine growth restriction, and infection.

    “In the case of fetal and neonatal deaths, causes of death may relate to severe malformations or chromosomal abnormalities, but are also often findings that can be compatible with live births too, such as placental insufficiency, intrauterine growth re­ striction, and infection (Varli et al., 2008).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Varli et al., 2008 source
  • May combine two claims.

    Interpretationreasoning
    § 1.2. Fetal development is uniquely susceptible to chemical exposures · p. 2

    Developing organisms are uniquely susceptible to perturbations like chemical exposures, and protecting fetuses will require studies addressing toxicity specifically in fetuses.

    “In summary, developing organisms are uniquely susceptible to perturbations like chemical exposures, and protecting fetuses will require studies addressing toxicity specifically in fetuses.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    The systematic summary presented normal ranges of these parameters across normal pregnancy, excluding women with pregnancy-related complications or conditions.

    “The ambitious work also presented the normal range of these parameters across normal pregnancy, excluding women with any pregnancy-related complications or conditions (Abduljalil et al., 2012).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Abduljalil et al., 2012 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning
    § 4.3. In silico models of fetal exposure · p. 11

    The accuracy of all PBPK models is highly dependent on the information that it is based upon.

    “The accuracy of all PBPK models is highly dependent on the information that it is based upon.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    Varying storage conditions, the type of plastics and instruments used in sampling, or the laboratory environment as a whole are unlikely to significantly impact levels of persistent chemicals in the sample.

    “In addition, varying storage conditions, the type of plastics and instruments used in sampling, or the laboratory environment as a whole are unlikely to significantly impact their levels in the sample.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    More rapidly metabolized chemicals, like many plastic additives such as bisphenols and phthalates, are more difficult to capture due to their fast kinetics; their levels can vary widely depending on the environment and exposure of the subject on any given day.

    “In contrast, more rapidly metabolized chemicals, like many plastic additives such as bisphenols and phthalates, are more difficult to capture due to their fast kinetics. Their levels can vary widely depending on the environment and expo­ sure of the subject on any given day.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationreasoning
    § 4.1. Overview of literature on chemicals in human fetal tissues · p. 8

    Considering the continued growth of the chemical industry, the amount of chemicals the fetus is exposed to is likely to increase.

    “Considering the continued growth of the chemical industry, both in terms of diversity and volume of chemicals, the amount of chemicals the fetus is exposed to is likely to increase.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Table 1 · p. 11

    It is likely that differing placental vascular resistance between pregnancies with female and male fetuses, the impact of maternal pregnancy complications often present in cases of intrauterine fetal demise, as well as dysfunction of the vasculature in placental insufficiency, may have played a role in how fetal sex and placental function affected fetal organ exposure.

    “However, it is likely that the differing placental vascular resistance between pregnancies with female and male fetuses, the impact of maternal pregnancy com­ plications that are often present in cases of intrauterine fetal demise, as well as the dysfunction of the vasculature in placental insufficiency, may have played a role (Figs. 2 and 3).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning
    § Table 1 · p. 11

    Factors such as maternal health and placental function should be taken into consideration when fetal chemical exposure is modelled.

    “Nevertheless, when viewed together, these observations suggest that factors such as maternal health and placental function should be taken into consideration when fetal chemical exposure is modelled.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning
    § 4.3. In silico models of fetal exposure · p. 11

    If the physicochemical properties of the chemical substance are well characterized, parameters affecting exposure as well as absorption, distribution, metabolism, and excretion are known, and accurate data on the concentration of the chemical in different compartments of the biological system is available for validation purposes, then it is likely that a good model can be developed.

    “If the physicochemical properties of the chemical substance are well characterized, parameters affecting exposure as well as absorption, distribution, metabolism, and excretion are known, and accurate data on the concentration of the chemical in different compartments of the biological system (in this case: the preg­ nant woman) is available for validation purposes, then it is likely that a”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    P-PBPK models were developed in the 1980s based on values measured in pregnant rodents, and human models started emerging a decade later.

    “P-PBPK models were developed in the 1980s based on values measured in pregnant rodents, and human models started emerging a decade later (Lu et al., 2012).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lu et al., 2012

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisereasoning
    § 4.3. In silico models of fetal exposure · p. 11

    Since pregnancy causes substantial changes in physiology, specific PBPK models for pregnancy (p-PBPK models) have been developed.

    “Since pregnancy causes substantial changes in physiology (Figs. 1 -2), specific PBPK models for pregnancy have been developed (so called p-PBPK models).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Pregnancy causes substantial changes in physiology.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning
    § 4.3. In silico models of fetal exposure · p. 11

    Non-linear accumulation of chemicals to organs could depend on changes in fetal blood flow patterns during development.

    “This non-linear accumulation of chemicals to organs could for example depend on changes in fetal blood flow patterns during development (Fig. 2).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    Sharma et al. developed a p-PBPK model for bisphenol A where the fetal compartment also encompassed organs like brain, liver, and kidney.

    “Sharma et al. developed a p-PBPK model for bisphenol A where the fetal compartment also encompassed organs like brain, liver, and kidney (Sharma et al., 2018).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Sharma et al., 2018 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    Validation of models on rapidly-metabolized compounds will remain challenging due to differing lifestyle variables just prior to sampling in biomonitoring studies and functional genetic variations in metabolizing enzymes in different populations.

    “Although the model by Sharma showed good potential, the authors acknowledged that validation of models on rapidly-metabolized com­ pounds will remain challenging due not only to differing lifestyle vari­ ables just prior sampling in biomonitoring studies, but also functional genetic variations in metabolizing enzymes in different populations.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Sharma et al., 2018 source
  • May combine two claims.

    Premisecitation
    § 5. Summary and future Directions · p. 11

    Exposure to adverse environments, such as malnutrition or toxic chemicals, can permanently shape the developing organs of the fetus, changing post-natal growth trajectory and conferring differing susceptibility to disease later in life.

    “Exposure to adverse environments, be it malnutrition or toxic chemicals, can permanently shape the developing organs of the fetus in a way that changes post-natal growth trajectory and confers differing susceptibility to disease later in life.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Barker et al., 1986 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 5. Summary and future Directions · p. 11

    Gestational diabetes affects 14% of all pregnancies.

    “gestational diabetes affects 14% of all pregnancies (Wang et al., 2022)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Wang et al., 2022 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning
    § 4.3. In silico models of fetal exposure · p. 11

    The main challenge of human p-PBPK models is the validation process.

    “The main challenge of the p-PBPK models in humans is the validation process.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation
    § 4.3. In silico models of fetal exposure · p. 11

    The Sharma model predicted higher mid-gestation exposure in the fetal liver, in agreement with some observational studies.

    “The model predicted higher mid-gestation exposure in the fetal liver in agreement with some observational studies.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Sharma et al., 2018 source
  • May combine two claims.

    Premisenone given
    § 5. Summary and future Directions · p. 12

    These studies establish that variation in chemical concentration between individuals is very high and not often explained by gestational length or maternal exposure levels.

    “ii) the variation in chemical concentration between individuals is very high, and not often explained by gestational length or maternal exposure levels.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or autopsies of stillborn infants.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § 5. Summary and future Directions · p. 11

    The concept of prenatal life as a defining, sensitive window of development has become well established since David Barker presented his hypothesis of adult heart disease being linked to poor nutrition during fetal development in the 1980s.

    “Since David Barker presented his hypothesis of adult heart disease being linked to poor nutrition during fetal development in the 1980s, the concept of prenatal life as a defining, sensitive window of development has become well established (Barker et al., 1986).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Barker et al., 1986 source
60 of 60
  • The paper relies on this without support.

    Placental function is regulated by imprinted genes.

    “Placental function is also regulated by imprinted genes.”
  • The paper relies on this without support.

    Aberrations in imprinting can lead to abnormal fetal growth.

    “aberrations in imprinting can lead to abnormal fetal growth.”
  • The paper relies on this without support.

    Imprinted genes are expressed in a parent-of-origin manner, with either the maternal or paternal allele silenced by DNA methylation.

    “Their expression pattern is dictated in a parent-of-origin manner so that either the maternal or paternal allele is silenced by the epigenetic mechanism of DNA methylation.”
  • The paper relies on this without support.

    IGF2 promotes both placental development and fetal growth.

    “IGF2 - a growth factor which promotes both placental development and fetal growth.”
  • The paper relies on this without support.

    Pregnancy causes substantial changes in physiology.

    “Since pregnancy causes substantial changes in physiology (Figs. 1 -2)”
  • The authors state this as an assumption.

    Persistent chemicals are easier to measure in tissue samples than rapidly metabolized chemicals.

    “presumably because they are easier to measure in tissue samples”
  • The paper relies on this without support.

    Pregnancy-related complications are always a risk factor to the mother and the fetus, leading to issues such as preterm birth, low birth weight, and even post-natal developmental aberrations.

    “Pregnancy-related complications are always a risk factor to the mother and the fetus , leading to issues such as preterm birth, low birth weight, and even post-natal developmental aberrations.”
  • The paper relies on this without support.

    Exposure in fetuses is typically only estimated based on concentration of chemicals in the mother.

    “exposure in fetuses is typically only estimated based on concentration of chem­ icals in the mother.”
  • The paper relies on this without support.

    Studies of chemical exposure during gestation tend to select 'normal healthy women' and uncomplicated pregnancies.

    “There is a clear tendency to select ' normal healthy women ' and uncomplicated pregnancies when chemical exposures during gestation are studied.”
  • The paper relies on this without support.

    The placenta is a crucial organ for both maternal and fetal health, and functional variations are common.

    “The placenta is a crucial organ for both maternal and fetal health, and functional variations are common.”
  • The paper relies on this without support.

    A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or autopsies of stillborn infants.

    “A handful of studies have measured chemical concentrations in human fetal tissues collected from elective pregnancy terminations or from autopsies of stillborn infants.”
11 of 11

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Studies include infants born alive despite the stated sample restriction

    Minor

    The text says the available tissue studies came from pregnancies without a viable birth, but Table 1 includes sudden infant deaths and samples from infants as old as 6.5 months postpartum.

1 of 1

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Nishimura, 1977, Levels of polychlorinated biphenyls and organochlorine insecticides in human embryos and fetuses, Paediatrician, 6

Cited by

Sorted by citations

Authors
Vinnars, M.-T., Bixo, M., & Damdimopoulou, P.
Affiliations
  • Umeå University (SE)
  • Karolinska University Hospital (SE)
Corresponding author
Damdimopoulou, Pauliina
Venue
Molecular and Cellular Endocrinology
Publisher
Elsevier BV
Published
2023-12
Volume
578
Pages
112064
ISSN
0303-7207 (ISSN-L)
OpenAlex
W4386470738
Cited by
32
References
110
Citations by year
2026: 10 · 2025: 12 · 2024: 9 · 2023: 1
FWCI
3.25
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Endocrinology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
Funders
  • European Commission (HORIZON2020, 952516)
  • Svenska Forskningsrådet Formas
  • Karolinska Institutet
  • Vetenskapsrådet (2020-01621, 2018-)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
pregnancy, placental function, pregnancy complications, fetal sex differences, fetal organ development, prenatal exposure
MeSH terms
Adaptation, Physiological, Animals, Female, Fetus, Humans, Maternal-Fetal Exchange, Placenta, Pregnancy, Maternal Exposure, Fetal Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review